Cargando…

Understanding competing risks: a simulation point of view

BACKGROUND: Competing risks methodology allows for an event-specific analysis of the single components of composite time-to-event endpoints. A key feature of competing risks is that there are as many hazards as there are competing risks. This is not always well accounted for in the applied literatur...

Descripción completa

Detalles Bibliográficos
Autores principales: Allignol, Arthur, Schumacher, Martin, Wanner, Christoph, Drechsler, Christiane, Beyersmann, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135581/
https://www.ncbi.nlm.nih.gov/pubmed/21639902
http://dx.doi.org/10.1186/1471-2288-11-86
_version_ 1782208127583649792
author Allignol, Arthur
Schumacher, Martin
Wanner, Christoph
Drechsler, Christiane
Beyersmann, Jan
author_facet Allignol, Arthur
Schumacher, Martin
Wanner, Christoph
Drechsler, Christiane
Beyersmann, Jan
author_sort Allignol, Arthur
collection PubMed
description BACKGROUND: Competing risks methodology allows for an event-specific analysis of the single components of composite time-to-event endpoints. A key feature of competing risks is that there are as many hazards as there are competing risks. This is not always well accounted for in the applied literature. METHODS: We advocate a simulation point of view for understanding competing risks. The hazards are envisaged as momentary event forces. They jointly determine the event time. Their relative magnitude determines the event type. 'Empirical simulations' using data from a recent study on cardiovascular events in diabetes patients illustrate subsequent interpretation. The method avoids concerns on identifiability and plausibility known from the latent failure time approach. RESULTS: The 'empirical simulations' served as a proof of concept. Additionally manipulating baseline hazards and treatment effects illustrated both scenarios that require greater care for interpretation and how the simulation point of view aids the interpretation. The simulation algorithm applied to real data also provides for a general tool for study planning. CONCLUSIONS: There are as many hazards as there are competing risks. All of them should be analysed. This includes estimation of baseline hazards. Study planning must equally account for these aspects.
format Online
Article
Text
id pubmed-3135581
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31355812011-07-14 Understanding competing risks: a simulation point of view Allignol, Arthur Schumacher, Martin Wanner, Christoph Drechsler, Christiane Beyersmann, Jan BMC Med Res Methodol Research Article BACKGROUND: Competing risks methodology allows for an event-specific analysis of the single components of composite time-to-event endpoints. A key feature of competing risks is that there are as many hazards as there are competing risks. This is not always well accounted for in the applied literature. METHODS: We advocate a simulation point of view for understanding competing risks. The hazards are envisaged as momentary event forces. They jointly determine the event time. Their relative magnitude determines the event type. 'Empirical simulations' using data from a recent study on cardiovascular events in diabetes patients illustrate subsequent interpretation. The method avoids concerns on identifiability and plausibility known from the latent failure time approach. RESULTS: The 'empirical simulations' served as a proof of concept. Additionally manipulating baseline hazards and treatment effects illustrated both scenarios that require greater care for interpretation and how the simulation point of view aids the interpretation. The simulation algorithm applied to real data also provides for a general tool for study planning. CONCLUSIONS: There are as many hazards as there are competing risks. All of them should be analysed. This includes estimation of baseline hazards. Study planning must equally account for these aspects. BioMed Central 2011-06-03 /pmc/articles/PMC3135581/ /pubmed/21639902 http://dx.doi.org/10.1186/1471-2288-11-86 Text en Copyright ©2011 Allignol et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Allignol, Arthur
Schumacher, Martin
Wanner, Christoph
Drechsler, Christiane
Beyersmann, Jan
Understanding competing risks: a simulation point of view
title Understanding competing risks: a simulation point of view
title_full Understanding competing risks: a simulation point of view
title_fullStr Understanding competing risks: a simulation point of view
title_full_unstemmed Understanding competing risks: a simulation point of view
title_short Understanding competing risks: a simulation point of view
title_sort understanding competing risks: a simulation point of view
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135581/
https://www.ncbi.nlm.nih.gov/pubmed/21639902
http://dx.doi.org/10.1186/1471-2288-11-86
work_keys_str_mv AT allignolarthur understandingcompetingrisksasimulationpointofview
AT schumachermartin understandingcompetingrisksasimulationpointofview
AT wannerchristoph understandingcompetingrisksasimulationpointofview
AT drechslerchristiane understandingcompetingrisksasimulationpointofview
AT beyersmannjan understandingcompetingrisksasimulationpointofview